Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study

The American Journal of Psychiatry
Marius K NickelPatrick Kaplan

Abstract

Aripiprazole is a relatively new atypical antipsychotic agent that has been successfully employed in therapy for schizophrenia and schizoaffective disorders. A few neuroleptics have been used in therapy for patients with borderline personality disorder, which is associated with severe psychopathological symptoms. Aripiprazole, however, has not yet been tested for this disorder, and the goal of this study was to determine whether aripiprazole is effective in the treatment of several domains of symptoms of borderline personality disorder. Subjects meeting criteria for the Structured Clinical Interview for DSM-III-R Personality Disorders for borderline personality disorder (43 women and 9 men) were randomly assigned in a 1:1 ratio to 15 mg/day of aripiprazole (N=26) or placebo (N=26) for 8 weeks. Primary outcome measures were changes in scores on the symptom checklist (SCL-90-R), the Hamilton Depression Rating Scale (HAM-D), the Hamilton Anxiety Rating Scale (HAM-A), and the State-Trait Anger Expression Inventory and were assessed weekly. Side effects and self-injury were assessed with a nonvalidated questionnaire. According to the intent-to-treat principle, significant changes in scores on most scales of the SCL-90-R, the HAM-D, ...Continue Reading

Associated Clinical Trials

Citations

Sep 12, 2007·Der Nervenarzt·M Bohus, C Schmahl
Feb 24, 2007·Psychopharmacology·Marius K NickelFrancisco Pedrosa Gil
Apr 15, 2010·The Psychiatric Quarterly·K Látalová, J Prasko
Oct 25, 2011·The Psychiatric Quarterly·Maria LucaCarmela Calandra
Jan 30, 2007·Current Psychiatry Reports·Deanna Mercer
Dec 9, 2010·Current Psychiatry Reports·Louis Feurino, Kenneth R Silk
Mar 6, 2010·Social Cognitive and Affective Neuroscience·Julia DmitrievaYuan-Chun Ding
Nov 22, 2012·Current Opinion in Psychiatry·Katrin SchroederIngo Schäfer
Aug 10, 2011·Depression Research and Treatment·Silvio BellinoFilippo Bogetto
Nov 22, 2013·Journal of Personality Disorders·Giles Newton-HowesRobert Schoevers
Aug 20, 2014·The Medical Clinics of North America·Amelia N Dubovsky, Meghan M Kiefer
Mar 3, 2010·Annual Review of Clinical Psychology·Matthew K Nock
Feb 2, 2008·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Nathan J KollaPaul S Links
Dec 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·S Charles SchulzSara Corya
Jan 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Klaus LiebJutta M Stoffers
Feb 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Tim KendallAnthony Bateman
Sep 28, 2010·Indian Journal of Pharmacology·Bindu Susan VargheseSaleh Bin Mohammed Al Khusaiby
Sep 20, 2011·International Review of Psychiatry·Joel Paris
Sep 22, 2011·Expert Opinion on Pharmacotherapy·Michael Rosenbluth, Mark Sinyor
Oct 27, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Sabine C HerpertzUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP)
Oct 31, 2012·The Psychiatric Clinics of North America·William J Newman
Jan 5, 2010·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Lars WöckelFritz Poustka
Mar 5, 2010·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Paul Lukas PlenerGerhard Libal
Sep 20, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Wolfgang HarthAndreas Hillert
May 21, 2014·Journal of the American Association of Nurse Practitioners·Hiba Wehbe-Alamah, Susan Wolgamott
Sep 20, 2007·Expert Opinion on Drug Safety·Camilla Haw, Jean Stubbs
Feb 16, 2011·The International Journal of Neuropsychopharmacology·Luis H RipollLarry J Siever
Feb 2, 2017·Journal of Clinical Psychopharmacology·Jesús Salomón Martínez, Asur Rahuel Sánchez Caballero
Sep 12, 2009·Journal of Clinical Psychopharmacology·Erika F H Saunders, Kenneth R Silk
Mar 18, 2008·Journal of Clinical Psychopharmacology·Frédérique Van den EyndeKurt Audenaert
Mar 8, 2016·The Mental Health Clinician·Karen E MoellerGrant Holmes
Jan 8, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Brianna J TurnerAlexander L Chapman
Jun 22, 2016·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Jillian H BroadbearSathya Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here